Page last updated: 2024-12-06

arpromidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arpromidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65895
CHEMBL ID293802
SCHEMBL ID138015
SCHEMBL ID9710060
MeSH IDM0168278

Synonyms (28)

Synonym
1-[3-(4-fluorophenyl)-3-pyridin-2-ylpropyl]-2-[3-(3h-imidazol-4-yl)propyl]guanidine
gtpl1221
PDSP1_001312
PDSP2_001296
arpromidine
CHEMBL293802
1-[3-(4-fluorophenyl)-3-pyridin-2-ylpropyl]-2-[3-(1h-imidazol-5-yl)propyl]guanidine
L000115
arpromidine [inn]
arpromidina [inn-spanish]
(+-)-1-(3-(p-fluorophenyl)-3-(2-pyridyl)propyl)-3-(3-imidazol-4-ylpropyl)guanidine
guanidine, n-(3-(4-fluorophenyl)-3-(2-pyridinyl)propyl)-n'-(3-(1h-imidazol-4-yl)propyl)-
unii-85713mt0eh
85713mt0eh ,
106669-71-0
arpromidinum [inn-latin]
arpromidina
arpromidinum
cas_65895
bdbm86171
nsc_65895
(+/-)-1-(3-(p-fluorophenyl)-3-(2-pyridyl)propyl)-3-(3-imidazol-4-ylpropyl)guanidine
SCHEMBL138015
SCHEMBL9710060
1-[3-(4-fluorophenyl)-3-(2-pyridyl)propyl]-n2-[3-(1h-imidazol-4-yl)propyl]guanidine
Q27074513
n-[3-(4-fluorophenyl)-3-(pyridin-2-yl)propyl]-n''-[3-(1h-imidazol-5-yl)propyl]guanidine
DTXSID50869467

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"N1-Aryl(heteroaryl)alkyl-N2-[3-(1H-imidazol-4-yl)propyl]guanidines are potent histamine H2-receptor (H2R) agonists, but their applicability is compromised by the lack of oral bioavailability and CNS penetration."( Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
Bernhardt, G; Buschauer, A; Dove, S; Elz, S; Ghorai, P; Götte, C; Igel, P; Keller, M; Kraus, A; Schneider, E; Schnell, D; Seifert, R; Zabel, M, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID345023Agonist activity at histamine H2 receptor in guinea pig spontaneously beating right atrium assessed as positive chronotropic activity2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
AID345024Agonist activity at histamine H2 receptor in guinea pig spontaneously beating right atrium assessed as positive chronotropic activity relative to histamine2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
AID78247Chronotropic effect assessed from maximal increase in delta LV (dp/dtmax) in isolated perfused guinea pig heart1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID88179Histamine H2 receptor agonism relative to histamine on isolated guinea pig right atrium1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID86892Antagonist activity at histamine H1 receptor against histamine in isolated ileum of guinea pig.1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID88003Intrinsic activity (as a measure of agonism) on electrically stimulated papillary muscle of guinea pig1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID88031Potency relative to histamine calculated from mean pD2 value in guinea pig right atrium.1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID88001Histamine H2 receptor agonistic activity (as a measure of agonism) at the isolated right atrium of guinea pig, activity relative to histamine.1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID88162Agonistic activity relative to histamine on electrically stimulated papillary muscle of guinea pig1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID345028Antagonist activity at histamine H1 receptor in guinea pig ileum assessed as inhibition of histamine-induced positive chronotropic activity2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
AID78248Increase in coronary flow with maximal inotropic response in isolated perfused guinea pig heart1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID76023Increase in heart rate with maximal inotropic response in isolated perfused guinea pig heart1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID77503Relative potency with impromidine (100%) in isolated perfused guinea pig heart1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
AID1346095Human H2 receptor (Histamine receptors)2006The Journal of pharmacology and experimental therapeutics, Apr, Volume: 317, Issue:1
Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
AID1346037Human H1 receptor (Histamine receptors)2003The Journal of pharmacology and experimental therapeutics, Jun, Volume: 305, Issue:3
Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
AID1346037Human H1 receptor (Histamine receptors)2006The Journal of pharmacology and experimental therapeutics, Apr, Volume: 317, Issue:1
Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's7 (50.00)18.2507
2000's6 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.48 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]